BACKGROUND: Myofascial pain is characterized by the presence of trigger points, tenderness to palpation, and local or referred pain, and commonly involves the pelvic floor muscles in men and women. Pelvic floor myofascial pain in the absence of local or referred pain has also been observed in patients with lower urinary tract symptoms, and we have found that many patients report an improvement in these symptoms after receiving myofascial-targeted pelvic floor physical therapy. OBJECTIVE: We sought to systematically review the literature for examination techniques used to assess pelvic floor myofascial pain in women. STUDY DESIGN: We performed a systematic literature search using strategies for the concepts of pelvic floor disorders, myofascial pain, and diagnosis in Ovid MEDLINE 1946-, Embase 1947-, Scopus 1960 Register of Controlled Trials, Database of Abstracts of Reviews of Effects, and Cochrane Database of Systematic Reviews. Articles were screened by 3 authors and included if they contained a description of a pelvic myofascial physical examination.
Introduction
Myofascial pain arising from the pelvic (levator ani [LA] ) and internal hip (obturator internus [OI] ) muscles and connective tissue is common in patients with chronic pelvic pain (CPP) and pelvic floor disorder symptoms. 1e3 It has also been observed in men with chronic prostatitis, men and women with bladder pain syndrome/interstitial cystitis, and women with vulvar pain. 4 Myofascial pain is characterized by the presence of trigger points, 1 tenderness to palpation, and local or referred pain, 4 which can result in debilitating CPP. In 1 study, 60e85% of patients with CPP reported tenderness upon physical examination of the LA and OI muscles. 5, 6 Multiple theories exist regarding the etiology of myofascial pain though none have been validated in the literature. One theory suggests that myofascial pain derives from metabolic changes occurring at the level of the motor endplate that causes hyperactivity of the muscle or microscopic muscle damage. 4 It has also been proposed that myofascial pain involves changes, such as glial cell proliferation and neuronal cell loss, in the central nervous system, which could explain the referred pain patterns seen in myofascial pain pathology. 7 Finally, the chronic muscle contraction/spasm associated with myofascial pain has been theorized to be a compensatory mechanism for impairments in the LA architecture or high functional demands on the pelvic floor. 4 Pelvic floor myofascial pain in the absence of local or referred pain has also been observed in patients with lower urinary tract symptoms (LUTS) and other pelvic floor disorders such as pelvic organ prolapse. 2, 3, 5, 8 Preliminary data from our institution also support a correlation between the presence of myofascial pain in the LA and OI muscles and the degree of LUTS bother. 9, 10 We have found that these patients often report significant improvement in their LUTS after receiving myofascial-targeted pelvic floor physical therapy. As the possibility of an association between subclinical pelvic floor myofascial pain (ie, pelvic floor myofascial pain identified on physical examination but not associated with symptomatic pelvic pain) and LUTS has received little study to date, few physicians may be trained to assess pelvic floor myofascial pain in the differential diagnosis for patients presenting with these symptoms. LUTS and other visceral symptoms are often attributed solely to the end organ (bladder, bowel, uterus, and ovaries) and the pelvic floor muscles are not explored.
Unfortunately, a standardized and reproducible protocol for assessing LA and OI myofascial pain does not currently exist, and few providers evaluate for pelvic floor myofascial pain even in patients presenting with pelvic pain. Considering the growing evidence correlating myofascial pain with CPP syndromes and emerging data suggesting a link between subclinical myofascial pain and LUTS, 2, 3, 5, 6, 9, 10 as well as the availability of myofascial-targeted therapies, a thorough and evidence-based physical examination for myofascial pain is necessary. As we are primarily interested in further understanding the relationship between pelvic floor myofascial pain and LUTS in patients who may seek care from general or subspecialist gynecologists, we sought examination strategies for the assessment of myofascial pain in women. Furthermore, although some components of the pelvic floor myofascial examination may be similar in males and females, the approach to access these muscles is different, so we chose to focus on examination strategies in women for this systematic review. This will both aid in assessment of and guide treatment for patients presenting with pelvic floor symptoms including pelvic pressure, heaviness, and LUTS. The objective of our study is to systematically review the literature on examination techniques for the diagnosis of LA and OI myofascial pain in women.
Materials and Methods
A comprehensive literature search was performed using strategies created by a medical librarian for the concepts of pelvic floor disorders, myofascial pain, and diagnosis using the following terms for: (1) pelvic floor disorders: "pelvic floor disorders," "disorders of the pelvic floor," "pelvic floor dysfunctions," "dysfunctions of the pelvic floor," "pelvic floor diseases," "diseases of the pelvic floor," and "syndrome of the pelvic floor"; (2) myofascial pain: "myofascial pain syndromes," "spasm," "trigger points," "pain," "ache," "myalgia," "chronic pain," "myofascial pain," "painful defecation," "dysuria," "pelvic girdle pain," "pelvic pain," "perineal pain," "postoperative pain," "vaginal pain," "vulvodynia," "muscle spasm," "myofascial syndrome," "muscle soreness," "muscle tenderness," and "pelvic pain syndrome"; and (3) assessment methodology: "diagnosis," "differential diagnosis," "sensitivity and specificity," "physical examination," "evaluation," and "assessment." Studies containing any of the terms for all 3 concepts (pelvic floor disorders, myofascial pain, and assessment) were captured and reviewed for eligibility. These strategies were implemented in Ovid MEDLINE 1946-, Embase 1947-, Scopus 1960-, Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effects, and Cochrane Database of Systematic Reviews. We reviewed the references of the identified studies to add any additional relevant studies.
All searches were completed in June 2017 and results were exported to EndNote. The full strategies for Ovid MEDLINE, Embase, Cochrane Library, and Scopus are available in the supplementary material. We defined the following inclusion criteria: (1) adults (age >18 years), (2) majority female (>50% of study population), and (3) studies reporting a description of the pelvic floor myofascial examination.
The results of the systematic search were screened independently by 2 authors (M.R.M., N.S.) and were included if there was any mention of a pelvic examination used to assess pelvic muscle pain. The resulting studies were then reviewed thoroughly and independently by 3 authors (M.R.M., N.S., J.L.) and were included if they met the aforementioned inclusion criteria. All study designs that included a pelvic floor myofascial pain examination as part of their protocol were included. Articles were excluded if they exclusively reported on children/adolescents, males constituted >50% of the studied population, or the study described pelvic pain in the setting of a known mesh complication. In the event of a disagreement, the authors reviewed the study together and came to a consensus regarding whether it satisfied criteria for inclusion. Data extracted from included studies were study design, year of publication, study objective, inclusion criteria, exclusion criteria, concomitant pelvic floor disorders, primary diagnosis, diagnostic tools utilized, measured outcomes and results, and specific characteristics of the physical examination. Data extraction was performed in duplicate by 2 authors (M.R.M., N.S.) independently. Disagreements were resolved through discussion and consensus. From these data, a recommended examination sequence was developed that incorporated components when used by multiple studies. In the event that examination components differed among included studies, the component cited in the majority of the studies was selected for inclusion in the recommended examination sequence.
To assess the quality of examination descriptions and procedures, a scoring system was developed whereby studies were given 1 point for each key examination component reported in the study. The conduct and reporting of this systematic review closely adhered to the guidelines of the Preferred Reporting Items for Systematic Reviews AJOG at a Glance Why was this study conducted? This systematic review was performed in order to summarize and synthesize published examination strategies for the assessment of pelvic floor myofascial pain.
Key findings
Examination components for assessment of pelvic floor myofascial pain varied considerably and were often undefined.
What does this add to what is known?
We present a consensus examination sequence based on the findings of this systematic review that includes key examination components that should be included in a comprehensive evaluation for pelvic floor myofascial pain.
and Meta-Analyses guidelines. This study was prospectively registered with PROSPERO International prospective register of systematic reviews, (registration number CRD42017073701) and was exempt from institutional review board review.
Results
The initial search identified 5112 publications, 2075 of which were duplicates: 1823 removed by the automatic duplicate finder in EndNote and 252 duplicates removed by a medical librarian. We screened the resulting 3037 publications and excluded 2633 based on predefined inclusion and exclusion criteria, resulting in 404 full-text articles reviewed. As very few of these studies were performed to evaluate the pelvic floor myofascial examination itself, but instead used this examination as part of their research protocol for other study goals, we included all article types (from randomized controlled trials to expert opinion and review articles) to capture as many examination descriptions as possible. This resulted in a total sample size of 55 studies, including 9460 patients of which 9437 (99.8%) were women (Figure and (Table 1 ). There were no systematic reviews. Objectives of the included studies varied widely with 11 testing an intervention, 21 reporting on diagnostic criteria/pathology, and 23 evaluating findings/symptoms upon examination. Only 2 of the 55 included manuscripts studied the examination itself. One study defined terminology for investigators studying and reporting pelvic floor muscle evaluation, and specified that patient positioning and number of digits used in palpation should be reported. 48 The level of detail for included examination components varied greatly among the studies. Most (49/55, 89.0%) did not document counseling or consent prior to beginning the pelvic examination. Likewise, the majority of studies did not describe the position of the patient during the examination. Only 19/55 (34.5%) reported patient positioning, and of those, the majority (15/19, 78.9%) were dorsal lithotomy. Many studies (13/55; 23.6%) did not describe whether the examination was approached transvaginally or transrectally. The majority that did specify route suggested using a transvaginal examination (36/42, 85.7%). No studies included an isolated transrectal approach, but 6 (14.3%) recommend both transvaginal and transrectal approaches for the complete examination. Most authors used a single digit for palpation (34/55, 61.8%), but many (19/ 55, 34.5%) did not specify the number of digits to use on palpation, and most (38/ 55, 69.1%) did not explicitly mention use of gloves or lubrication.
The majority of studies (39/55, 70.9%) lacked a description of the method used to orient the examiner to the relevant muscles (Table 1) . Of the 16 studies that did describe a specific method for orientation, 3,14,22,26,28,33,35,37e39,43,46,49,54,56,59 all (16/16, 100%) used the clock-face method with the introitus at the center, the pubic bone at 12 o'clock, and the anus at 6 o'clock.
Among the included studies, there was a general agreement that the LA ajog.org 4,8,11,13,14,19,24,36,42,44,47,48,51,55e58 Of the studies that recommended examination of the LA muscles, some suggested palpation of the LA in general (23/55, 41.8%) 3,4,8,11e14,18,19,21,27,32,36,40,42,46,51, 55e57,59e61 whereas others specified which muscular components of the LA should be identified and palpated ( There was also variation in the use of instruments to standardize pressure and measure pain/pressure thresholds. Most studies (48/55, 87.3%) did not attempt to standardize the amount of pressure applied to muscle. 3,8,11e25,27,29e33,36e38 , 40,42e61 More recent studies (7/55, 12.7%) incorporated vaginal pressure algometers in an effort to increase interrater reliability and define pain/pressure thresholds 4, 26, 28, 34, 35, 39, 41 (Table 1 ). In all, 25 studies (45.5%) assessed pain on palpation of the pelvic floor muscles as part of the physical iliococcygeus (24/55), 2,15e17,20e23,28,29e31,33,34,37e39,43,45,49,50,52e54 coccygeus (18/55), 3,15e17,21,22,33,37e39,45,49,50,52e54,59,60 unspecified levator ani (23/55) 4,8,11e14,18,19,21,27,32,36,40,42,46,51,55e57,59e61 7. Then palpate obturator internus at 2 and 10 o'clock. 27/55 Studies palpated obturator internus for tenderness 2,3,12,16e18,20,21,24,25,27,28,30e32,37e39,44,45,50,52e54,59e61 Of these, 5/25 studies specified palpating obturator internus after palpating pelvic floor muscles 3, 24, 27, 44, 59 8. During palpation, apply pressure to specific sites predefined on each pelvic floor muscle and obturator internus. Consider vaginal pressure algometer to standardize amount of pressure being applied to each site. Table 3 outlines our recommended examination sequence based on the little consensus reported in the literature. The recommended examination includes counseling for the patient prior to the examination, identifying muscle location based on a clock-face method, palpating muscles at single sites midmuscle belly using a single digit, and quantifying self-reported pain upon palpation using a 0e10 validated scale (0e10; 0 ¼ no pain, 1e3 ¼ mild pain, 4e6 ¼ moderate pain, and 7e10 ¼ severe pain). Specifically, muscle palpation should include the bilateral LA and OI muscles, and trigger points should be noted. A vaginal pressure algometer can be considered in an attempt to standardize pressure applied on examination. Visual inspection and observation of the function of the pelvic floor should occur throughout the examination.
2,
We assessed study quality based on whether or not studies reported 8 key examination components. Studies were given 1 point for each key component reported and were then ranked by score with higher scores representing "higher quality" studies (Table 4) . Only 1 study reported all 8 key components 14 while 3 studies did not report any of the key components.
Comment
Despite the prevalence of pelvic floor myofascial pain in patients with CPP, no standardized protocol for the physical examination of myofascial pelvic pain currently exists. Findings from this systematic review illustrate that techniques for pelvic myofascial examination vary significantly and commonly are poorly defined among both investigational studies and clinical reviews. Furthermore, the overall level of evidence to guide standardization of a pelvic myofascial examination is poor. As a result, it is difficult to draw conclusions about the best methods to execute the myofascial pelvic pain examination, but here we recommend an examination sequence based upon the limited consensus within the literature to date.
As with all systematic reviews, this review is limited by the quality of the studies available for inclusion. Very few studies evaluated the examination itself, and no studies tested the validity or reproducibility of the examination for pelvic floor myofascial pain. Additionally, very few studies utilized vaginal pressure algometers or other methods to standardize the pressure applied during palpation, or consistent anatomic landmarks for identification of the ideal sites for palpation were lacking. Finally, as no quality appraisal tool exists to evaluate pelvic floor (or other) myofascial pain examination techniques, we had to generate an informal tool based on key examination components. This tool assigned points to studies based on whether or not key components were included within the examination description.
Despite the aforementioned limitations, we believe the common elements of previous examinationseie, our consensus-based guidelineseprovide a good foundation upon which to build an evidence-based protocol for the assessment of pelvic myofascial pain. Going forward, these examination elements should be tested and validated as reliable indicators of the presence and severity of pelvic floor myofascial pain in women. A standardized, evidence-based examination protocol is necessary to reduce misclassification as investigators begin studying the association between pelvic floor myofascial pain and other pelvic floor disorders like CPP and LUTS. Clinically, a standardized pelvic floor myofascial examination will improve the ajog.org identification of patients with pelvic floor myofascial pain as a contributing factor in their CPP, LUTS, or other pelvic floor disorder symptoms and who may benefit from myofascial-targeted therapies. Once this evidence-based, standardized examination is established, efforts can then turn to promoting physician education regarding the importance of assessing pelvic floor myofascial pain in women presenting with pelvic floor disorder symptoms. n
